LXRX - Lexicon Pharmaceuticals Q2 Earnings Preview August, 01 2022 05:35 PM Lexicon Pharmaceuticals Inc. Lexicon Pharmaceuticals ( NASDAQ: LXRX ) is scheduled to announce Q2 earnings results on Tuesday, August 2nd, after market close. The consensus EPS Estimate is -$0.16 and the consensus Revenue Estimate is $0.1M (-50.0% Y/Y). For further details see: Lexicon Pharmaceuticals Q2 Earnings Preview